NEW YORK (GenomeWeb) — Affymetrix and Ariosa Diagnostics today announced that they have signed a multi-year agreement under which Affymetrix will supply arrays and instruments for use in Ariosa's Harmony non-invasive prenatal test.

The deal "opens up the possibility to further broaden access to the Harmony test via a kit decentralization strategy," Ariosa CEO Ken Song said in a statement. Under such a strategy other laboratories would be able to run the array-based test in house.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.